ITHUF · iANTHUS CAPITAL HOLDINGS, INC.
$0.00
0.00 (-10.87%)
At close · Sep 4
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“While we believe that we have funding necessary for us to continue as a going concern, we may need to raise additional capital and there can be no assurance that such capital will be available to us on favorable terms, if at all. As such, these material circumstances cast substantial doubt on our ability to continue as a going concern for a period of no less than 12 months from the date of this report, and our unaudited interim condensed consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$32.08M
Shares
6.97B
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
52W close$0.00–0.01
Avg vol 30d123K
Short int44K · 0.0% float · 1.0d
Short vol72%
DataJan 2020–Sep 2026
Filing10-Q · Aug 12
Up next
filed Aug 12, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$139.54M
Trailing 12 months
Net income (TTM)
−$55.37M
Trailing 12 months
Revenue growth YoY
+0.5%
Year over year
Operating margin
-9.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-69.8%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$195.27M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.2%
Year over year · more shares
Price change (1Y)
-18.0%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.5 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−15%
below
Price vs 50-day avg
−7%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
6%
near low
Momentum
relative strength
1-month return
+8%
trailing
6-month return
+3%
trailing
YTD return
−18%
this year
Relative strength
−13%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · ▲ +5.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 5-yr low, contrarian setup
Squeeze score
30
low risk · 0–100
Fundamentals
Revenue growth
−14%
Y/Y
Gross margin
46%
expanding
Free cash flow
$-20.6M
Balance sheet
$182.1M
net debt
Quant / Vol
risk profile
Volatility
191%
annualized · 1-yr
Max drawdown
−58%
past year
ATR
19.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−15%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
6%
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · ▲ +5.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 5-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 6%
Range high $0
vs 200-day avg -15%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ITHUF
this stock
iANTHUS CAPITAL HOLDINGS, INC.
|
$32.08M | -18.0% | -14.1% | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$59.75B | +18.3% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$47.50B | -5.8% | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.83B | -5.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
1
- % held
- 0.0%
- Net QoQ
- 0 sh
- Top holder
- Byrne Asset Management LLC
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ITHUF | -12.8% | +7.9% | +2.5% | -8.9% | -18.0% |
| SPY | +0.1% | -0.4% | +15.1% | +0.4% | +12.9% |
| vs SPY | -12.9% | +8.3% | -12.6% | -9.3% | -30.9% |